Literature DB >> 34073699

Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology.

Mazen Osman1, Zeynettin Akkus2, Dragan Jevremovic3, Phuong L Nguyen3, Dana Roh3, Aref Al-Kali4, Mrinal M Patnaik4, Ahmad Nanaa4, Samia Rizk5, Mohamed E Salama3.   

Abstract

The accurate diagnosis of chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML) subtypes with monocytic differentiation relies on the proper identification and quantitation of blast cells and blast-equivalent cells, including promonocytes. This distinction can be quite challenging given the cytomorphologic and immunophenotypic similarities among the monocytic cell precursors. The aim of this study was to assess the performance of convolutional neural networks (CNN) in separating monocytes from their precursors (i.e., promonocytes and monoblasts). We collected digital images of 935 monocytic cells that were blindly reviewed by five experienced morphologists and assigned into three subtypes: monocyte, promonocyte, and blast. The consensus between reviewers was considered as a ground truth reference label for each cell. In order to assess the performance of CNN models, we divided our data into training (70%), validation (10%), and test (20%) datasets, as well as applied fivefold cross validation. The CNN models did not perform well for predicting three monocytic subtypes, but their performance was significantly improved for two subtypes (monocyte vs. promonocytes + blasts). Our findings (1) support the concept that morphologic distinction between monocytic cells of various differentiation level is difficult; (2) suggest that combining blasts and promonocytes into a single category is desirable for improved accuracy; and (3) show that CNN models can reach accuracy comparable to human reviewers (0.78 ± 0.10 vs. 0.86 ± 0.05). As far as we know, this is the first study to separate monocytes from their precursors using CNN.

Entities:  

Keywords:  artificial intelligence; chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML) for acute monoblastic leukemia and acute monocytic leukemia; concordance between hematopathologists; digital imaging; improving diagnosis accuracy; monocytes; promonocytes and monoblasts

Year:  2021        PMID: 34073699     DOI: 10.3390/jcm10112264

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  13 in total

1.  Flow cytometric analysis of different CD14 epitopes can help identify immature monocytic populations.

Authors:  David T Yang; Jay H Greenwood; Leah Hartung; Sally Hill; Sherrie L Perkins; David W Bahler
Journal:  Am J Clin Pathol       Date:  2005-12       Impact factor: 2.493

Review 2.  Update on the pathologic diagnosis of chronic myelomonocytic leukemia.

Authors:  Daniel A Arber; Attilio Orazi
Journal:  Mod Pathol       Date:  2019-02-05       Impact factor: 7.842

Review 3.  Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.

Authors:  Mrinal M Patnaik; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2018-06       Impact factor: 10.047

4.  Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia.

Authors:  Esperanza Such; Ulrich Germing; Luca Malcovati; José Cervera; Andrea Kuendgen; Matteo G Della Porta; Benet Nomdedeu; Leonor Arenillas; Elisa Luño; Blanca Xicoy; Mari L Amigo; David Valcarcel; Kathrin Nachtkamp; Ilaria Ambaglio; Barbara Hildebrandt; Ignacio Lorenzo; Mario Cazzola; Guillermo Sanz
Journal:  Blood       Date:  2013-01-31       Impact factor: 22.113

5.  Morphological evaluation of monocytes and their precursors.

Authors:  Jean E Goasguen; John M Bennett; Barbara J Bain; Teresa Vallespi; Richard Brunning; Ghulam J Mufti
Journal:  Haematologica       Date:  2009-06-16       Impact factor: 9.941

Review 6.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

7.  The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.

Authors:  Gong Xubo; Lu Xingguo; Wu Xianguo; Xu Rongzhen; Xiao Xibin; Wang Lin; Zhu Lei; Zhang Xiaohong; Xu Genbo; Zhao Xiaoying
Journal:  Eur J Haematol       Date:  2009-06-02       Impact factor: 2.997

8.  Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.

Authors:  Chiara Elena; Anna Gallì; Esperanza Such; Manja Meggendorfer; Ulrich Germing; Ettore Rizzo; Jose Cervera; Elisabetta Molteni; Annette Fasan; Esther Schuler; Ilaria Ambaglio; Maria Lopez-Pavia; Silvia Zibellini; Andrea Kuendgen; Erica Travaglino; Reyes Sancho-Tello; Silvia Catricalà; Ana I Vicente; Torsten Haferlach; Claudia Haferlach; Guillermo F Sanz; Luca Malcovati; Mario Cazzola
Journal:  Blood       Date:  2016-07-06       Impact factor: 22.113

Review 9.  Deep Learning for Brain MRI Segmentation: State of the Art and Future Directions.

Authors:  Zeynettin Akkus; Alfiia Galimzianova; Assaf Hoogi; Daniel L Rubin; Bradley J Erickson
Journal:  J Digit Imaging       Date:  2017-08       Impact factor: 4.056

10.  Fully Automated Segmentation of Bladder Sac and Measurement of Detrusor Wall Thickness from Transabdominal Ultrasound Images.

Authors:  Zeynettin Akkus; Bae Hyung Kim; Rohit Nayak; Adriana Gregory; Azra Alizad; Mostafa Fatemi
Journal:  Sensors (Basel)       Date:  2020-07-27       Impact factor: 3.576

View more
  1 in total

Review 1.  Clinical Applications of Artificial Intelligence-An Updated Overview.

Authors:  Ștefan Busnatu; Adelina-Gabriela Niculescu; Alexandra Bolocan; George E D Petrescu; Dan Nicolae Păduraru; Iulian Năstasă; Mircea Lupușoru; Marius Geantă; Octavian Andronic; Alexandru Mihai Grumezescu; Henrique Martins
Journal:  J Clin Med       Date:  2022-04-18       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.